Evaluation of Biological Activities of Extracts and Chemical Constituents of Mimusops elengi
Purpose: To isolate some compounds from the leaves and bark of Mimusops elengi, and examine them for their antibacterial and anti-inflammatory properties.
Experimental: The compounds were isolated from the leaf and bark chloroform extracts using column chromatography, and characterized using physical and spectroscopic methods. The isolated compounds and their respective extracts were tested for antibacterial activity by micro-dilution antibacterial assay, and for anti-inflammatory activity by cyclooxygenase inhibitory assay.
Results: of the compounds isolated include spinasterol (1), ursolic acid (2) and 3β, 6β, 19α, 23- tetrahydroxyurs-12-en-28-oic acid (3) from the leaves; and taraxerol (4) and spinasterol β-Dglucopyranoside (5) from the bark. A majority of the samples showed good activity against Staphylococcus aureus (9.7 ─ 78.0 μg/mL), while moderate activity was observed against Gramnegative bacteria (78.0 ─ 156 μg/mL). Strong COX inhibition was observed for the leaf extract, and (1); selective COX-2 inhibition for (2) and (3); and selective COX-1 inhibition for bark extract, (4) and (5).
Conclusion: This is the first report describing the anti-inflammatory potential of M. elengi on the basis of its isolated constituents. The results of this study support the traditional use of the plant as antibacterial and anti-inflammatory remedy.
Keywords: Mimusops elengi, Sapotaceae, Steroids; Triterpenoids, Antibacterial, Antiinflammatory.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.